Short link N acts as a disease modifying osteoarthritis drug.

Antoniou, J; Epure, L M; Grant, M P; Richard, H; Sampalis, J; Roughley, P J; Laverty, S; Mwale, F

Antoniou, J; Epure, L M; Grant, M P; Richard, H; Sampalis, J; Roughley, P J; Laverty, S; Mwale, F.

Affiliation

Mwale F; Orthopaedics Research Laboratory, Lady Davis Institute for Medical Research, SMBD-Jewish General Hospital, Department of Experimental Surgery, Faculty of Medicine, McGill University, Montréal, QC, Canada.fmwale2jgh.mcgill.ca.

Eur Cell Mater ; 37: 347-359, 2019 05 02.

Article in En | MEDLINE | ID: mdl-31044415

Subject(s)

Extracellular Matrix Proteins/metabolism; Extracellular Matrix Proteins/pharmacology; Osteoarthritis/drug therapy; Osteoarthritis/metabolism; Proteoglycans/metabolism; Proteoglycans/pharmacology; Animals; Anterior Cruciate Ligament/drug effects; Anterior Cruciate Ligament/metabolism; Anterior Cruciate Ligament Injuries/drug therapy; Anterior Cruciate Ligament Injuries/metabolism; Cartilage, Articular/drug effects; Cartilage, Articular/metabolism; Disease Models, Animal; Disease Progression; Femur/drug effects; Femur/metabolism; Injections, Intra-Articular/methods; Knee Joint/drug effects; Knee Joint/metabolism; Rabbits; Tibia/drug effects; Tibia/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoarthritis / Proteoglycans / Extracellular Matrix Proteins Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur Cell Mater Year: 2019 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google